A Study to Explore if Long-term Use of Mucinex Can Help With Symptoms in Patients With Stable Chronic Bronchitis.

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 17, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

November 13, 2024

Conditions

Chronic Bronchitis

Interventions

DRUG

Guafenesin tablets

During the 12-week period of receiving treatment, patient participants will take Mucinex® 12h, 2 x 600 mg (1200 mg total) twice daily.

Trial Locations (2)

American Health Research, Charlotte

Clinical Research of Rock Hill, Rock Hill